AUTL (STOCKS)
Autolus Therapeutics plc American Depositary Share
$2.240000
+0.120000 (+5.66%)
Prev close: $2.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christian Martin Itin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $691.36M
- Employees
- 647
- P/E (TTM)
- -2.11
- P/B (TTM)
- 10.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.15 | $-0.22 | +0.0700 | +31.82% |
|
Mar 2026 (Q1)
|
$-0.27 | $-0.26 | -0.0077 | -2.94% |
|
Dec 2025 (Q4)
|
$-0.34 | $-0.27 | -0.0684 | -25.18% |
|
Sep 2025 (Q3)
|
$-0.30 | $-0.23 | -0.0698 | -30.32% |
Financial Statements
| Revenues | $117.39M |
| Benefits Costs and Expenses | $396.87M |
| Cost Of Revenue | $99.01M |
| Costs And Expenses | $396.87M |
| Gross Profit | $18.38M |
| Nonoperating Income/Loss | -$32.04M |
| Operating Expenses | $265.82M |
| Selling, General, and Administrative Expenses | $153.19M |
| Research and Development | $112.63M |
| Operating Income/Loss | -$247.44M |
| Income/Loss From Continuing Operations After Tax | -$280.16M |
| Income/Loss From Continuing Operations Before Tax | -$279.48M |
| Income Tax Expense/Benefit | $677.00K |
| Interest Expense, Operating | $41.81M |
| Net Income/Loss | -$280.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$280.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$280.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.06 |
| Diluted Earnings Per Share | -$1.06 |
| Basic Average Shares | 532,294,307 |
| Diluted Average Shares | 532,294,307 |
| Assets | $493.23M |
| Current Assets | $336.09M |
| Inventory | $33.43M |
| Prepaid Expenses | $19.34M |
| Other Current Assets | $283.33M |
| Noncurrent Assets | $157.14M |
| Fixed Assets | $60.52M |
| Other Non-current Assets | $96.61M |
| Liabilities | $418.39M |
| Current Liabilities | $68.79M |
| Accounts Payable | $1.37M |
| Wages | $19.66M |
| Other Current Liabilities | $47.76M |
| Noncurrent Liabilities | $349.60M |
| Equity | $74.84M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $74.84M |
| Liabilities And Equity | $493.23M |
| Net Cash Flow From Operating Activities | -$225.61M |
| Net Cash Flow From Operating Activities, Continuing | -$225.61M |
| Net Cash Flow From Investing Activities | $286.14M |
| Net Cash Flow From Investing Activities, Continuing | $286.14M |
| Net Cash Flow From Financing Activities | -$7.77M |
| Net Cash Flow From Financing Activities, Continuing | -$7.77M |
| Exchange Gains/Losses | -$5.18M |
| Net Cash Flow | $47.58M |
| Net Cash Flow, Continuing | $52.76M |
| Comprehensive Income/Loss | -$285.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$287.12M |
| Other Comprehensive Income/Loss | -$332.33M |
| Other Comprehensive Income/Loss Attributable To Parent | -$6.96M |